Immuneering Corporation

NASDAQ:IMRX

1.71 (USD) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -15,046.132-18.051-14.597-14.08-14.308-15.083-12.595-12.189-13.604-13.246-12.844-11.527-12.896-10.784-8.534-7.988-6.23-5.836-4.399-3.604-3.201
Depreciation & Amortization 92.5780.1750.0960.0980.1880.0970.086-0.020.190.1890.205-0.0830.2010.0520.0380.0350.0340.0320.0160.0160.015
Deferred Income Tax 00000-0.620.62000000-13.5130000000
Stock Based Compensation 1,692.2671.7251.641.6621.4751.6411.4791.3341.2741.0481.0661.0520.8980.6330.6370.3510.1820.2170.310.2880.272
Change In Working Capital 01.692-0.6580.724-2.6841.884-0.7950.027-2.0910.4741.0480.782-0.5861.046-1.1831.164-0.1260.1340.587-0.0670.599
Accounts Receivables 00000-0.01200.0010.0110.0580.1080.101-0.0340.2510.024-0.0030.0080.078-0.2780.049-0.139
Change In Inventory 00000000000000.194-149.6140-29.447000-29.556
Change In Accounts Payables -687.8710.057-0.6790.3930.1170.171-0.778-0.068-0.4310.8161.098-0.4020.248-0.4450.3630.064-0.1120.2740.31-0.2680.869
Other Working Capital 01.6350.0220.331-2.8011.713-0.0160.094-1.671-0.4-0.1591.083-0.8011.046148.0441.10329.425-0.2180.5550.15229.425
Other Non Cash Items -819.351-0.050.0470.071.571-0.313-0.8220.1-0.186-0.214-0.096-0.2210.10413.3270.0090.360.3540.2740.31-0.2680.869
Operating Cash Flow -14,080.638-14.511-13.472-11.526-15.491-11.775-12.027-10.748-14.418-11.749-10.622-9.449-12.281-9.239-9.035-6.437-6.14-5.453-3.486-3.367-2.314
Investing Activities:
Investments In Property Plant And Equipment -8.945-0.009-0.005-0.033-0.037-0.171-0.057-0.087-0.028-0.069-0.393-0.165-0.115-0.013-0.011-0.02-0.017-0.038-0.006-0.005-0.004
Acquisitions Net 00000-3.30423.91500-41.8310.487000.070000000
Purchases Of Investments 00000-15.746-28.91500-12.378-19.737-10.009-7.98-22.865-52.76000000
Sales Maturities Of Investments 05.50521.4319.0559.251920.619.2532.32820.500000000
Other Investing Activites 00-5.41021.433.304-23.9159.251941.831-0.48722.31912.520.07-52.76000000
Investing Cash Flow -8.9455.491-5.4154.96721.3933.133-23.9729.16318.9728.152-0.8822.15412.405-22.808-52.772-0.02-0.017-0.038-0.006-0.005-0.004
Financing Activities:
Debt Repayment 000000000000000000000
Common Stock Issued 13,676.667-5.2174.23700.980.0080.02128.172239.408-0.185-0.0170.0280.1930.008118.48925.76900000
Common Stock Repurchased 133.89200000000000000000000
Dividends Paid 000000000000000000000
Other Financing Activities 13,810.559-0.0410.12700.980.0080.02128.1720.239-0.185-0.0170.0280.1930.008118.48925.769036.984000.998
Financing Cash Flow 13,810.559-0.0414.36500.980.0080.02128.1720.239-0.185-0.0170.0280.1930.008118.48925.769036.984000.998
Other Information:
Effect Of Forex Changes On Cash 00000-36.79936.79900000000000000
Net Change In Cash -279.024-9.061-14.523-6.5596.881-8.634-35.97726.5874.793-3.781-11.5212.7320.317-32.03956.68219.311-6.15631.493-3.492-3.373-1.32
Cash At End Of Period 35,865.69636.14545.20659.72866.28759.40668.04104.01777.4372.63776.41887.93775.20574.888106.92850.24530.93437.095.5979.08912.462